The event features a conversation with John Elling and Kristin Martinez, the founders from Acoustic Cytometry Systems. We’ll explore their beginnings, development and (most importantly), recent exit.
Date: Thursday, January 22, 2009
Time: 6 – 8 pm
Venue: Prairie Star, 288 Prairie Star Rd, Bernalillo, NM
Map: Google Map
About Kristin Martinez
Kristin Martinez is the founder and CEO of Sound Point Ventures, a new venture development and management company started in Seattle in 1998. Through Sound Point she created and manages Angels with Attitude, the first active angel fund focused on sustainable cleantech investments. Most recently, Kristin was a founder, director and CFO of biotech startup Acoustic Cytometry Systems, Inc., in Los Alamos, NM. The angel-funded company was sold to Invitrogen after 27 months. Kristin spent 10 years in the electric utility industry, most recently as Chief Operating Officer and Treasurer of Pepco Energy Services, Inc., an unregulated spinout from Potomac Electric Power Company (now Pepco Holdings, Inc.). Kristin has a BS from Boston University and an MBA in Finance and Investments from The George Washington University.
About John Elling, PhD, MBA
After receiving a Ph.D. in Analytical Chemistry from the University of Wisconsin, John Elling started his career in New Mexico in 1991 as a Technical Staff Member at Los Alamos National Laboratory. In 1998, he left the Lab to start Bioreason which grew to 30 plus employees, marketing its data mining and computational intelligence information technology to automate high throughput screening data analysis. In 2001, he started Cytoprint, which, until its acquisition by Atto Bioscience, developed image analysis technology for biological assay discovery. Three years ago, as CEO of Integrated Genomics in Chicago, Elling redirected the company’s business into bioinformatics, initially downsizing to achieve profitability and then ramping up a 15% to 25% CAGR and arranged a 6x merger. As a Visiting Entrepreneur at Los Alamos in 2005, he helped develop the business plan for Acoustic Cytometry Systems and later led the company until it was acquired in 2008 by Invitrogen.
